#
##
##
##
|||Pages|
|---|---|---|
|Trustees'
annual
report||1 to 11|
|Independent
examiner's
report to the trustees||12|
|Statement offinancial|activities|13|
|Statement offinancial|position|14|
|Notes to the financial|statements|15to 20|
|The following
pages|do not form part ofthe financial statements||
|Detailed statement
of|financial activities|22 to 23|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
Pag9 5
Ladies Fighting Breast Cancer Charitable Trust
Trustees. Annual Report
Year ended 31st August 2021
##
##
##
#
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||2021|2021|2020|
|---|---|---|---|---|---|---|
|||||Unrestricted|||
|||||funds|Total funds|Total funds|
||||Note|6|6|E|
|Income and endowments|||||||
|Donations
and legacies|||4|76,870|76,870|105,969|
|Other trading
activities|||5|956|956|3,509|
|Investment
income|||6|5|5|59|
|Total income||||77,831|77,831|109,537|
|Expenditure|||||||
|Expenditure
on raising funds:|||||||
|Costs of raising donations||and legacies|7|83,909|83,909|63,085|
|Costs ofother trading|activities||8|10,114|10,114|8,172|
|Expenditure
on charitable|activities||9,10|26,852|26,852|14,200|
|Total expenditure||||120,875|120,875|85,457|
|Net (expenditure)/income|and|net movement|ln funds|(43,044)|(43,044)|24,080|
|Reconciliation
offunds|||||||
|Total funds
brought
forward||||75,702|75,702|51,622|
|Total funds carried forward||||32,658|32,658|75,702|
##
##
||||||2021||2020|
|---|---|---|---|---|---|---|---|
|||||Note||||
|Fixed assets||||||||
|Tangible fixed assets||||15||1,145|1,872|
|Current assets||||||||
|Stocks||||16|1,100||1,500|
|Debtors||||17|5,619||3,043|
|Cash at bank and|in|hand|||31,994||76,487|
||||||38,713||81,030|
|Creditors: amounts||falling|due within one year|18|(7,200)||(7,200)|
|Net current assets||||||31,513|73,830|
|Total assets less|current||liabilities|||32,658|75,702|
|Net assets||||||32,658|75,702|
|Funds ofthe charity||||||||
|Unrestricted
funds||||||32,658|75,702|
|Total charity funds||||19||32,658|75,702|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|---|---|---|---|---|---|---|---|---|---|
|||||||Funds
f|2021
f|Funds
6|2020
F|
||Costs of raising donations||||and|||||
||legacies - Donations|||||83,909|83,909|63,085|63,085|
|8.|Costs ofother trading|||activities||||||
|||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|||||||Funds|2021|Funds|2020|
|||||||6||6|6|
||Merchandise|costs||||||43|43|
||Fundralsing|Events||||10,114|10,114|8,129|8,129|
|||||||10,114|10,114|8,172|8,172|
|9.|Expenditure|on charitable|||activities|by fund type||||
|||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|||||||Funds|2021|Funds|2020|
|||||||6||6|6|
||Discretionary|payments||to|Breast|||||
||Cancer patients|||||7,862|7,862|5,777|5,777|
||Funding
ofsupport||network||for Breast|||||
||Cancer patients|||||10,985|10,985|1,985|1,985|
||Support costs|||||8,005|8,005|6,438|6,438|
|||||||26,852|26,852|14,200|14,200|
|10.|Expenditure|on charitable|||activities|by activity type||||
|||||||Activities||||
|||||||undertaken|Support|Total funds|Total fund|
|||||||directly|costs|2021|2020|
||||||||6|||
||Discretionary|payments||to|Breast|||||
||Cancer patients|||||7,862||7,862|5,777|
||Funding
of support||network||for Breast|||||
||Cancer patients|||||10,985||10,985|1,985|
||Governance|costs|||||8,005|8,005|6,438|
|||||||18,847|8,005|26,852|14,200|
|11.|Analysis of|support costs||||||||
|||||||Accountancy|Legal fees|Total 2021|Total 2020|
|||||||6|8||F|
||Governance|costs||||3,673|4,333|8,006|4,069|
##
##
##
##
##
|12.|Net (expenditure)/income||Year|ende|d 31stAugust|d 31stAugust|2021||||
|---|---|---|---|---|---|---|---|---|---|---|
||Net (expenditure)/income||is stated|after|charging/(crediting):||||||
||||||||||2021|2020|
|||||||||||E|
||Depreciation
oftangible|fixed assets|||||||727|696|
|13.|Independent
examination||fees||||||||
||||||||||2021|2020|
|||||||||||f|
||Fees payable
to the independent|||examiner||for:|||||
||Independent
examination||of the financial
statements||||||3,600|3,600|
||Other financial
services||||||||73|169|
||||||||||3,673|3,769|
|14.|Staff costs and emoluments||||||||||
||The total staff costs and|employee||benefits||for the reporting|period are|analysed
as follows:|||
||'The average head count|of employees|||during the year was||Nil (2020: Nil).||||
||No employee
received employee|||benefits||of more than E60,000 during||the|year (2020: Nil).||
||Consultancy
fees of630,000 (2020:f28,500)were paid to||||||the Trustees|during
the year.|||
|15.|Tangible fixed assets||||||||||
|||||||||Equipment||Total|
||||||||||E||
||Cost||||||||||
||At 1st September
2020|and 31stAugust||||2021|||15,439|15,439|
||Depreciation||||||||||
||At 1st September 2020||||||||13,567|13,567|
||Charge for the year||||||||727|727|
||At 31stAugust 2021||||||||14,294|14,294|
||Carrying
amount||||||||||
||At 31stAugust
2021||||||||1,145|1,145|
||At 31stAugust 2020||||||||1,872|1,872|
|16.|Stocks||||||||||
||||||||||2021|2020|
|||||||||||f|
||Finished goods||||||||1,100|1,500|
##
##
##
##
|17.|Debtors|||Year ended 31stAugust 202|1||
|---|---|---|---|---|---|---|
||||||2021|2020|
|||||||f:|
||Prepayments|and accrued||income|1,847|65|
||Other debtors||||3772|2,978|
||||||5,619|3,043|
|18.|Creditors: amounts||falling|due within one year|||
||||||2021|2020|
|||||||F|
||Accruals and|deferred|income||7,200|7,200|
##
||||||At|||At|
|---|---|---|---|---|---|---|---|---|
|||||1st|September|||31stAugust|
||||||2020|Income|Expenditure|2021|
||||||f:||||
||General|funds|||75,702|77,831|(120,875)|32,658|
||||||At|||At|
|||||1st|September|||31stAugust|
||||||2019|Income|Expenditure|2020|
||||||5|F|5||
||General|funds|||51,622|109,537|(85,457)|75,702|
|20.|Analysis|of net assets between||funds|||||
||||||||Unrestricted|Total Funds|
||||||||Funds|2021|
||||||||f|F|
||Tangible|fixed assets|||||1,145|1,145|
||Current|Assets|||||38,713|38,713|
||Creditors|less than|1 year||||(7,200)|(7,200|
||Net assets||||||32,658|32,658|
||||||||Unrestricted|Total Funds|
||||||||Funds|2020|
||||||||f:|F|
||Tangible|fixed assets|||||1,872|1,872|
||Current|Assets|||||81,030|81,030|
||Creditors|less than|1 year||||(7,200)|(7,200|
||Net assets||||||75,702|75,702|
|Unrestricted|Total|Funds|
|---|---|---|
|Funds||2021|
|f||F|
|1,145||1,145|
|38,713||38,713|
|(7,200)||(7,200)|
|32,658||32,658|
|Unrestricted|Total|Funds|
|Funds||2020|
|f:||F|
|1,872||1,872|
|81,030||81,030|
|(7,200)||(7,200)|
|75,702||75,702|
##
##
|Notes to|the Detailed Statement of Financial|Activities||
|---|---|---|---|
||Year ended 31stAugust 2021|||
|||2021|2020|
|||8|8|
|Income and endowments||||
|Donations
and legacies||||
|Sundry donations||26,211|47,788|
|Grants||50,659|58,181|
|||76,870|105,969|
|Other trading
activities||||
|Ticket sales for fundraising|events|956|3,509|
|Investment
Income||||
|Bank interest receivable|||59|
|Total Income||77,831|109,537|
##
##
##
||||Yea|r ended 31stAugust|2021||
|---|---|---|---|---|---|---|
|Expenditure|||||||
|Costs of raising donations|||and legacies||||
|Rent and storage costs|||||3,827|3,366|
|IT and software costs||||||3,734|
|Oflice costs|||||424|654|
|Insurance|||||880|715|
|Motor vehicle|and travel|expenses|||5,653|1,930|
|Consultancy|fees||||60,111|39,483|
|Advertising
and promotional|||expenses||10,719|11,376|
|Depreciation|||||727|696|
|Telephone|||||1,107|749|
|Postage and|stationery||||257|347|
|Bank charges|||||204|33|
||||||83,909|63,085|
|Costs ofother trading||activities|||||
|Purchases||||||43|
|Venue costs||||||4,268|
|Other event costs|||||10,114|3,661|
||||||10,114|8,172|
|Expenditure|on charitable||activities||||
|Payments
to patients||and|support|groups|||
|Discretionary|payments|to Breast Cancer patients|||7,862|5,777|
|Support groups|||||10,985|1,985|
||||||18,847|7,762|
|Governance|costs||||||
|Accountancy|fees||||3,673|4,069|
|Legal and other professional|||fees||4,332|1,410|
|Governance|costs - costs oftrustees'|||meetings||959|
||||||8,005|6,438|
|Expenditure|on charitable||activities||26,852|14,200|
|Total expenditure|||||120,875|85,457|
|Net (expenditure)/Income|||||(43,044)|24,080|